The Valley Desk

Clinical trial reportBreast cancer research : BCRPublished

TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Breast cancer research : BCR
Published
Subject terms
Humans; Paclitaxel; Nitriles; Pyrazoles; Pyrimidines; Antineoplastic Combined Chemotherapy Protocols; Interleukin-6; Treatment Outcome; Neoadjuvant Therapy; Female; Inflammatory Breast Neoplasms; Triple Negative Breast Neoplasms
PubMed ID
38297352
PubMed Central ID
PMC10829369
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal